Literature DB >> 32206240

Recent developments on zinc(ii) metal-organic framework nanocarriers for physiological pH-responsive drug delivery.

Weicong Liu1, Ying Pan1, Weiwei Xiao2, Hongjia Xu1, Dong Liu3, Fei Ren4, Xinsheng Peng1, Jianqiang Liu1.   

Abstract

The high storage capacities and excellent biocompatibilities of zinc(ii) metal-organic frameworks (Zn-MOFs) have made them outstanding candidates as drug delivery carriers. Recent studies on the pH-responsive processes based on carrier-drug interactions have proven them to be the most efficient and effective way to control the release profiles of drugs. To satisfy the ever-growing demand in cancer therapy, great efforts are being devoted to the development of methods to precisely control drug release and achieve targeted use of an active substance at the right time and place. In this review article, we discuss the diverse stimuli based on Zn-MOFs carriers that have been achieved upon external activation from single pH-stimulus-responsive or/and multiple pH-stimuli-responsive viewpoints. Also, the perspectives and future challenges in this type of carrier system are discussed. This journal is © The Royal Society of Chemistry 2019.

Entities:  

Year:  2019        PMID: 32206240      PMCID: PMC7069377          DOI: 10.1039/c9md00400a

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  107 in total

1.  A new copper-based metal-organic framework as a promising heterogeneous catalyst for chemo- and regio-selective enamination of β-ketoesters.

Authors:  Ying Zhao; Dong-Sheng Deng; Lu-Fang Ma; Bao-Ming Ji; Li-Ya Wang
Journal:  Chem Commun (Camb)       Date:  2013-11-11       Impact factor: 6.222

2.  Methane storage in metal-organic frameworks.

Authors:  Yabing He; Wei Zhou; Guodong Qian; Banglin Chen
Journal:  Chem Soc Rev       Date:  2014-08-21       Impact factor: 54.564

3.  Zeolite-like metal-organic frameworks (ZMOFs): design, synthesis, and properties.

Authors:  Mohamed Eddaoudi; Dorina F Sava; Jarrod F Eubank; Karim Adil; Vincent Guillerm
Journal:  Chem Soc Rev       Date:  2014-10-24       Impact factor: 54.564

4.  Dual-Stimulus-Triggered Programmable Drug Release and Luminescent Ratiometric pH Sensing from Chemically Stable Biocompatible Zinc Metal-Organic Framework.

Authors:  Kai Xing; Ruiqing Fan; Fengyou Wang; Huan Nie; Xi Du; Shuang Gai; Ping Wang; Yulin Yang
Journal:  ACS Appl Mater Interfaces       Date:  2018-06-20       Impact factor: 9.229

5.  Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.

Authors:  Shen-Zhen Ren; Dan Zhu; Xiao-Hua Zhu; Bin Wang; Yu-Shun Yang; Wen-Xue Sun; Xiao-Ming Wang; Peng-Cheng Lv; Zhong-Chang Wang; Hai-Liang Zhu
Journal:  ACS Appl Mater Interfaces       Date:  2019-05-28       Impact factor: 9.229

6.  Combined Fenton and starvation therapies using hemoglobin and glucose oxidase.

Authors:  Hadi Ranji-Burachaloo; Amin Reyhani; Paul A Gurr; Dave E Dunstan; Greg G Qiao
Journal:  Nanoscale       Date:  2019-03-21       Impact factor: 7.790

Review 7.  Enzyme-MOF (metal-organic framework) composites.

Authors:  Xizhen Lian; Yu Fang; Elizabeth Joseph; Qi Wang; Jialuo Li; Sayan Banerjee; Christina Lollar; Xuan Wang; Hong-Cai Zhou
Journal:  Chem Soc Rev       Date:  2017-06-06       Impact factor: 54.564

8.  A Metal Organic Framework with Spherical Protein Nodes: Rational Chemical Design of 3D Protein Crystals.

Authors:  Pamela A Sontz; Jake B Bailey; Sunhyung Ahn; F Akif Tezcan
Journal:  J Am Chem Soc       Date:  2015-09-03       Impact factor: 15.419

9.  Multifunctional System Polyaniline-Decorated ZIF-8 Nanoparticles as a New Chemo-Photothermal Platform for Cancer Therapy.

Authors:  Janine S F Silva; José Y R Silva; Gilberto F de Sá; Silvany S Araújo; Manoel A Gomes Filho; Célia M Ronconi; Thiago C Santos; Severino A Júnior
Journal:  ACS Omega       Date:  2018-09-27

10.  Stimuli-responsive nucleic acid-functionalized metal-organic framework nanoparticles using pH- and metal-ion-dependent DNAzymes as locks.

Authors:  Wei-Hai Chen; Xu Yu; Alessandro Cecconello; Yang Sung Sohn; Rachel Nechushtai; Itamar Willner
Journal:  Chem Sci       Date:  2017-06-06       Impact factor: 9.825

View more
  6 in total

1.  Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.

Authors:  Zahra Gharehdaghi; Rahmatollah Rahimi; Seyed Morteza Naghib; Fatemeh Molaabasi
Journal:  J Biol Inorg Chem       Date:  2021-08-22       Impact factor: 3.358

2.  Controlled Transdermal Release of Antioxidant Ferulate by a Porous Sc(III) MOF.

Authors:  Génesis Osorio-Toribio; Miriam de J Velásquez-Hernández; Paulo G M Mileo; J Antonio Zárate; Javier Aguila-Rosas; Gerardo Leyva-Gómez; Roberto Sánchez-Sánchez; Jonathan J Magaña; Mario Alberto Pérez-Díaz; Isabel Abánades Lázaro; Ross S Forgan; Guillaume Maurin; Enrique Lima; Ilich A Ibarra
Journal:  iScience       Date:  2020-05-11

Review 3.  Metal-Organic Frameworks and Their Composites Towards Biomedical Applications.

Authors:  Yana Ma; Xianglong Qu; Cui Liu; Qiuran Xu; Kangsheng Tu
Journal:  Front Mol Biosci       Date:  2021-12-21

Review 4.  Zinc-Based Metal-Organic Frameworks in Drug Delivery, Cell Imaging, and Sensing.

Authors:  Rashda Safdar Ali; Hongmin Meng; Zhaohui Li
Journal:  Molecules       Date:  2021-12-24       Impact factor: 4.411

5.  Targeted Codelivery of Prodigiosin and Simvastatin Using Smart BioMOF: Functionalization by Recombinant Anti-VEGFR1 scFv.

Authors:  Somayyeh Mirzaeinia; Sedighe Zeinali; Nediljko Budisa; Hamid Reza Karbalaei-Heidari
Journal:  Front Bioeng Biotechnol       Date:  2022-03-24

6.  Sulfadiazine hosted in MIL-53(Al) as a biocide topical delivery system.

Authors:  Javier Águila-Rosas; Tomás Quirino-Barreda; Gerardo Leyva-Gómez; Eduardo González-Zamora; Ilich A Ibarra; Enrique Lima
Journal:  RSC Adv       Date:  2020-07-07       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.